Form 4 Filing for IGC Pharma, Inc.

This filing details a transaction by Mukunda Ram, CEO and Director of IGC Pharma, Inc. (IGC). On September 25, 2026, Ram disposed of 200,000 shares of Common Stock. The disposal was made at a price of $0.0 per share, with 100,000 shares disposed of in each of two transactions. Following these transactions, Ram owns 6,675,563 shares. The footnote indicates that these shares belong to Ram's two children who do not share his household. This transaction is classified as a disposal of shares.